Ausgabe 2/2022
Inhalt (10 Artikel)
Skin Cancer (T Ito, Section Editor)
Management of Cutaneous Angiosarcoma: an Update Review
Siwei Bi, Ai Zhong, Xiya Yin, Jingyi Li, Ying Cen, Junjie Chen
Lymphoma (JL Muñoz, Section Editor).
Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment
Allison M. Bock, Grzegorz S. Nowakowski, Yucai Wang
Open Access
Lymphoma (JL Muñoz, Section Editor)
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Arushi Khurana, Yi Lin
Neuro-oncology (GJ Lesser, Section Editor)
Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy
Feng Yuan, Yingshuai Wang, Chiyuan Ma
Sarcoma (SH Okuno, Section Editor)
Systemic Therapy for Chondrosarcoma
Adam Rock, Sana Ali, Warren A. Chow
Gynecologic Cancers (JS Ferriss, Section Editor)
Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma
Morgan Pugh-Toole, Anna P. Nicolela, Sarah Nersesian, Brendan M. Leung, Jeanette E. Boudreau
Gynecologic Cancers (JS Ferriss, Section Editor)
Radical Hysterectomy After the LACC Trial: Back to Radical Vaginal Surgery
Denis Querleu, Delphine Hudry, Fabrice Narducci, Agnieszka Rychlik
Cardio-oncology (MG Fradley, Section Editor)
Cardiotoxicity of Systemic Melanoma Treatments
Neha Mukunda, Srilakshmi Vallabhaneni, Benedicte Lefebvre, Michael G. Fradley
Head and Neck Cancer (PL Swiecicki, Section Editor)
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer
Roberto N. Solis, Dustin A. Silverman, Andrew C. Birkeland
Lung Cancer (TA Leal and N Sethakorn, Section Editors)
Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective
Harleen Kaur Walia, Parul Sharma, Navneet Singh, Siddharth Sharma